Where can I find news about AI?

The latest headlines, third-party analysis, and SEC filings for C3.ai, Inc. (AI) are listed on this page. Headlines come from across the financial press; filings come directly from SEC EDGAR.

Where are AI's SEC filings?

C3.ai, Inc. (AI)'s 10-K (annual report), 10-Q (quarterly report), 8-K (current report), and proxy filings are listed in the SEC Filings section on this page with direct links to the official EDGAR copies.

Where are AI's earnings call transcripts?

Full earnings call transcripts for C3.ai, Inc. (AI) — prepared remarks plus speaker-by-speaker analyst Q&A — live on the Earnings tab, alongside the Earnings Reports section that links each quarter's press release and SEC report.

C3.ai, Inc.

NYSE·Software, Application · Technology

$10.46$0.44−4.04%

Market cap$1.59B·Market closed·Sep 4 8:00 PM UTC

News & Analysis

UNDP and NEC Sign Memorandum of Understanding on the Use of AI and Other Digital Technologies to Realize a Nature-Positive Society
TOKYO, Sept 7, 2026 - (JCN Newswire) - The United Nations Development Programme (UNDP) and NEC Corporation (NEC) have signed a Memorandum of Understanding (MOU)
gurufocus.comSep 7, 2026 · 11:00 AM
Cognizant Invests in America's AI-Era Workforce
Cognizant Invests in America's AI-Era Workforce PR Newswire TEANECK, N.J., Sept. 7, 2026
gurufocus.comSep 7, 2026 · 10:00 AM
Hyosung Chairman Cho Hyun-Joon targets U.S. AI power market with 22.9kV SST
Hyosung Chairman Cho Hyun-Joon targets U.S. AI power market with 22.9kV SST PR Newswire SEOUL, South Korea, Sept.
gurufocus.comSep 7, 2026 · 10:00 AM
ETCAMAH® (camizestrant) in combination with a CDK4/6 inhibitor approved in the US for 1st-line advanced HR-positive breast cancer
AstraZeneca's ETCAMAHÂ (camizestrant) in combination with a cyclin-dependent kinase (CDK) 4/6 inhibitor (abemaciclib, palbociclib or ribociclib) has been appro
gurufocus.comSep 4, 2026 · 8:00 PM
C3.ai: Early Turnaround Signals Are Here (Upgrade)
C3.ai is upgraded to Buy, citing early signs of recovery under founder Thomas Siebel's renewed leadership. Q1 bookings surged over 70% sequentially, reflecting successful sales team restructuring and renewed customer momentum. AI's holistic enterprise AI stack and $650M cash position provide strategic flexibility and operational runway.
seekingalpha.comSep 3, 2026 · 3:04 PM
Keysight Collaborates with the Centre for Assuring Autonomy at the University of York to Advance AI Safety Assurance for Software-Defined Vehicles
[url="]Keysight Technologies, Inc.[/url] (NYSE: KEYS) and the [url="]Centre for Assuring Autonomy (CfAA)[/url] at the University of York (UK) announced a resear
gurufocus.comSep 3, 2026 · 11:00 AM
C3.ai: A Turnaround On Borrowed Time
C3.ai, Inc. is undergoing a turnaround led by returning CEO Thomas Siebel, focusing on execution and restructuring sales strategies. Q1 2027 showed progress: bookings up 73% QoQ, federal bookings up 138% YoY, and positive free cash flow of $2.1 million. Non-GAAP gross margin improved to 50% and operating expenses fell sharply after a 40% headcount reduction, but revenue remains down YoY.
seekingalpha.comSep 3, 2026 · 10:15 AM
C3.Ai Stock In Focus: Reports Q1 Double Beat — Then Guides Below Estimates
C3.Ai Inc. (NYSE:AI) is trending Thursday after the company reported first-quarter results Wednesday after market close.
benzinga.comSep 3, 2026 · 8:21 AM

SEC Filings

8-K
Sep 2, 2026View on SEC
ARS
Aug 27, 2026View on SEC
DEFA14A
Aug 27, 2026View on SEC
DEF 14A
Aug 27, 2026View on SEC
8-K
Aug 27, 2026View on SEC
8-K
Jul 17, 2026View on SEC

Frequently Asked Questions About AI

Where can I find news about AI?: The latest headlines, third-party analysis, and SEC filings for C3.ai, Inc. (AI) are listed on this page. Headlines come from across the financial press; filings come directly from SEC EDGAR.
Where are AI's SEC filings?: C3.ai, Inc. (AI)'s 10-K (annual report), 10-Q (quarterly report), 8-K (current report), and proxy filings are listed in the SEC Filings section on this page with direct links to the official EDGAR copies.
Where are AI's earnings call transcripts?: Full earnings call transcripts for C3.ai, Inc. (AI) — prepared remarks plus speaker-by-speaker analyst Q&A — live on the Earnings tab, alongside the Earnings Reports section that links each quarter's press release and SEC report.

C3.ai, Inc.

Frequently Asked Questions About AI

C3.ai, Inc.

UNDP and NEC Sign Memorandum of Understanding on the Use of AI and Other Digital Technologies to Realize a Nature-Positive Society

Cognizant Invests in America's AI-Era Workforce

Hyosung Chairman Cho Hyun-Joon targets U.S. AI power market with 22.9kV SST

ETCAMAH® (camizestrant) in combination with a CDK4/6 inhibitor approved in the US for 1st-line advanced HR-positive breast cancer

C3.ai: Early Turnaround Signals Are Here (Upgrade)

Keysight Collaborates with the Centre for Assuring Autonomy at the University of York to Advance AI Safety Assurance for Software-Defined Vehicles

C3.ai: A Turnaround On Borrowed Time

C3.Ai Stock In Focus: Reports Q1 Double Beat — Then Guides Below Estimates

Frequently Asked Questions About AI

UNDP and NEC Sign Memorandum of Understanding on the Use of AI and Other Digital Technologies to Realize a Nature-Positive Society

Cognizant Invests in America's AI-Era Workforce

Hyosung Chairman Cho Hyun-Joon targets U.S. AI power market with 22.9kV SST

ETCAMAH® (camizestrant) in combination with a CDK4/6 inhibitor approved in the US for 1st-line advanced HR-positive breast cancer

C3.ai: Early Turnaround Signals Are Here (Upgrade)

Keysight Collaborates with the Centre for Assuring Autonomy at the University of York to Advance AI Safety Assurance for Software-Defined Vehicles

C3.ai: A Turnaround On Borrowed Time

C3.Ai Stock In Focus: Reports Q1 Double Beat — Then Guides Below Estimates